All Posts

Can you take semaglutide or tirzepatide if you’re on insulin or metformin? This evidence-based guide explains which diabetes medications are compatible, what the ADA recommends, and how GLP-1/GIP therapy affects blood sugar and A1C.

Do GLP-1 medications directly cause vitamin malabsorption? Dr. Joshua Silva breaks down the clinical evidence on nutrition, hair loss, and the risks of over-supplementing during weight loss. Available for telehealth across Utah.

Early studies suggest GLP-1 medications like semaglutide and tirzepatide might protect brain health and lower dementia risk. Discover the science behind these claims, what Alzheimer's clinical trials actually show, and why promising observational signals aren't definitive proof yet.

Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD Yes—early research shows GLP-1 medications like semaglutide and tirzepatide may reduce cravings and reward-driven behaviors related to alcohol and other substances. However, they are not FDA-approved for addiction, and evidence varies by substance and study type.¹ How GLP-1 Medications Affect Addiction (Brain and Dopamine Explained) GLP-1 medications may influence addiction by modulating r

A physician-written review of the STEP 9 trial explaining how semaglutide improves knee osteoarthritis pain, how weight-loss milestones relate to knee replacement risk, and what this means for patients in Utah.

s taking GLP-1 medications every other week a good idea? Discover what 2025 pharmacologic models and clinical trials actually say about bi-weekly dosing, the risk of weight regain, and why consistent weekly treatment remains the gold standard for metabolic health.

Worried about muscle loss on Zepbound® or Ozempic®? Discover the specific protein targets and resistance training protocols required to preserve lean mass while taking GLP-1 medications.

The FDA has approved a higher weekly dose of Wegovy (semaglutide) at 7.2 mg. While clinical trials show this 3× increase can drive total body weight loss toward 20.7%, it also raises the risk of dose-dependent side effects like dysesthesia and GI distress. With no official titration guidelines yet available, Dr. Joshua Silva discusses how to approach this new dosage safely and who may benefit most from the increase.

"Food noise" isn’t just a buzzword—it’s a reflection of complex neurobiological signaling. Dr. Joshua Silva, MD, breaks down how GLP-1 medications like semaglutide and tirzepatide interact with the brain's reward centers to quiet persistent cravings and make sustainable weight loss achievable.

Early research from the 2026 AAOS Annual Meeting indicates that GLP-1 medications like Ozempic and Wegovy may be associated with a higher relative risk of tendon ruptures. However, with an absolute risk increase of less than 1%, most patients remain unaffected. Discover the proposed mechanisms—from rapid activity increases to collagen signaling—and how to mitigate risk while continuing therapy.

A physician-written guide to alcohol use on GLP-1 medications like Ozempic®, Wegovy®, Mounjaro®, and Zepbound®. Covers GI side effects, blood sugar risk, altered tolerance, and emerging research on cravings.

"GLP-1 microdosing" is a popular, patient-driven trend for medications like semaglutide and tirzepatide. Understand the clinical reality behind sub-therapeutic doses, split dosing, and weight maintenance strategies.

Feeling tired on Ozempic, Wegovy, or Zepbound? Fatigue is a documented side effect affecting up to 11% of patients. Explore the physiological reasons behind GLP-1 fatigue and learn evidence-based management strategies—like optimizing hydration and protein intake—with Dr. Joshua Silva, MD.

Not losing weight on semaglutide or tirzepatide? You’re not alone—and it doesn’t usually mean the medication failed. Learn the most common reasons weight loss can stall, what’s normal, and how to get results back on track with physician-guided care.

"Ozempic Face" is trending, but is it the medication or the weight loss causing the change? Dr. Silva separates the myths from the massive weight loss science, explains why some patients look "gaunt" while others don't, and reviews which treatments actually restore facial volume.

Is it safe to breastfeed while taking Ozempic® or Mounjaro®? While limited data suggests low transfer into breast milk, official FDA guidance remains cautious due to unknown long-term risks. Learn about the science of peptide transfer, washout periods, and why most clinicians recommend discontinuing GLP-1s during lactation.

Diarrhea is a common but usually temporary side effect of GLP-1 medications like Wegovy® and Zepbound®. This physician-reviewed guide explains why it happens, food triggers, dose considerations, and when symptoms need medical attention.

Constipation is a common side effect of GLP-1 medications like semaglutide and tirzepatide. Learn why it happens, how to fix it safely, and when to seek medical care.

Are sulfur burps and bloating ruining your GLP-1 progress? Many patients turn to digestive enzymes for relief, but the science shows a "mechanism mismatch." Discover why enzymes often fail to fix the "traffic jam" in your stomach—and when they might actually be worth a try.

Experiencing sulfur burps or a "stuck" feeling on Ozempic? Dr. Joshua Silva, MD explains the science of delayed gastric emptying and offers 6 actionable tips to reduce gas and bloating.